Evidence that vasopressin V 1b receptors mediate the transition to excessive drinking in ethanol-dependent rats

Addiction Biology

Volumn 17, Issue 1, 2012, Pages 76-85

  Edwards, Scott ^a   Guerrero, Miguel ^a   Ghoneim, Ola M ^a   Roberts, Edward ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Amygdala; ethanol dependence; vasopressin

Indexed keywords

ALCOHOL; NELIVAPTAN; VASOPRESSIN; VASOPRESSIN V1B RECEPTOR; CENTRAL DEPRESSANT AGENT; VASOPRESSIN RECEPTOR;

ADAPTATION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASOLATERAL AMYGDALA; CONTROLLED STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SIGNAL TRANSDUCTION; AMYGDALOID NUCLEUS; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG SELF ADMINISTRATION; STATISTICS; WESTERN BLOTTING; WISTAR RAT;

ALCOHOL DRINKING; ALCOHOLISM; AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MALE; RATS; RATS, WISTAR; RECEPTORS, VASOPRESSIN; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 84255198067     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2010.00291.x     Document Type: Article

References (62)

1. Aguilera G, Rabadan-Diehl C, (2000) Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat. Exp Physiol 85: Spec No:19S-26S.
2. Antoni FA, (1993) Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14: 76-122. (Pubitemid 23210952)
3. Beard JD, Sargent WQ, (1979) Water and electrolyte metabolism following ethanol intake and during acute withdrawal from ethanol. In:, Majchrowicz E, Noble EP, eds. Biochemistry and Pharmacology of Ethanol, vol. 2, pp. 3-16. New York: Plenum Press.
4. Brownstein MJ, Russell JT, Gainer H, (1980) Synthesis, transport, and release of posterior pituitary hormones. Science 207: 373-378. (Pubitemid 10147912)
5. Buijs RM, (1978) Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Pathways to the limbic system, medulla oblongata and spinal cord. Cell Tissue Res 192: 423-435. (Pubitemid 9028328)
6. Buijs RM, De Vries GJ, Van Leeuwen FW, Swaab DF, (1983) Vasopressin and oxytocin: distribution and putative functions in the brain. Prog Brain Res 60: 115-122.
7. Caldwell HK, Wersinger SR, Young WS, 3rd (2008) The role of the vasopressin 1b receptor in aggression and other social behaviours. Prog Brain Res 170: 65-72. (Pubitemid 352010221)
8. Chrousos GP, (2009) Stress and disorders of the stress system. Nature Rev Endocrinol 5: 374-381.
9. De Vries GJ, Buijs RM, (1983) The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum. Brain Res 273: 307-317. (Pubitemid 13039718)
10. de Wied D, Versteeg DH, (1979) Neurohypophyseal principles and memory. Fed Proc 38: 2348-2354. (Pubitemid 9252347)
11. Ebner K, Bosch OJ, Kromer SA, Singewald N, Neumann ID, (2005) Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids. Neuropsychopharmacology 30: 223-230. (Pubitemid 40129474)
12. Edwards S, Graham DL, Whisler KN, Self DW, (2009) Phosphorylation of GluR1, ERK, and CREB during spontaneous withdrawal from chronic heroin self-administration. Synapse 63: 224-235.
13. Edwards S, Koob GF, (2010) Neurobiology of dysregulated motivational systems in drug addiction. Future Neurol 5: 393-401.
14. Eisenhofer G, Lambie DG, Whiteside EA, Johnson RH, (1985) Vasopressin concentrations during alcohol withdrawal. Br J Addict 80: 195-199. (Pubitemid 16053500)
15. Engelmann M, Wotjak CT, Neumann I, Ludwig M, Landgraf R, (1996) Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehavioral Rev 20: 341-358. (Pubitemid 26313697)
16. Engin E, Treit D, (2008) Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus. Neuropeptides 42: 411-421.
17. Folny V, Raufaste D, Lukovic L, Pouzet B, Rochard P, Pascal M, Serradeil-Le Gal C, (2003) Pancreatic vasopressin V1b receptors: characterization in In-R1-G9 cells and localization in human pancreas. Am J Physiol Endocrinol Metab 285: E566-E576. (Pubitemid 37010835)
18. Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF, (2007) Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 61: 78-86. (Pubitemid 44855743)
19. Gilpin NW, Koob GF, (2008) Neurobiology of alcohol dependence: focus on motivational mechanisms. Alcohol Res Health 31: 185-195.
20. Gilpin NW, Richardson HN, Cole M, Koob GF, (2008) Vapor inhalation of alcohol in rats. Curr Protoc Neurosci, Chapter 9: Unit 9, 29.
21. Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, Soubrie P, (2002) Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci U S A 99: 6370-6375. (Pubitemid 34493318)
22. Griffante C, Green A, Curcuruto O, Haslam CP, Dickinson BA, Arban R, (2005) Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist. Br J Pharmacol 146: 744-751. (Pubitemid 41573625)
23. Heilig M, Koob GF, (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30: 399-406. (Pubitemid 47090230)
24. Hodgson RA, Higgins GA, Guthrie DH, Lu SX, Pond AJ, Mullins DE, Guzzi MF, Parker EM, Varty GB, (2007) Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression. Pharmacol Biochem Behav 86: 431-440. (Pubitemid 46466874)
25. Hoffman PL, Ishizawa H, Giri PR, Dave JR, Grant KA, Liu LI, Gulya K, Tabakoff B, (1990) The role of arginine vasopressin in alcohol tolerance. Ann Med 22: 269-274. (Pubitemid 20361866)
26. Hoffman PL, Ritzmann RF, Walter R, Tabakoff B, (1978) Arginine vasopressin maintains ethanol tolerance. Nature 276: 614-616. (Pubitemid 9087764)
27. Huber D, Veinante P, Stoop R, (2005) Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308: 245-248. (Pubitemid 40558858)
28. Hurbin A, Orcel H, Alonso G, Moos F, Rabie A, (2002) The vasopressin receptors colocalize with vasopressin in the magnocellular neurons of the rat supraoptic nucleus and are modulated by water balance. Endocrinology 143: 456-466. (Pubitemid 34107198)
29. Kalivas PW, (2005) How do we determine which drug-induced neuroplastic changes are important? Nature Neurosci 8: 1440-1441. (Pubitemid 41573652)
30. Kaufmann JE, Oksche A, Wollheim CB, Gunther G, Rosenthal W, Vischer UM, (2000) Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Investig 106: 107-116. (Pubitemid 30437246)
31. Koob GF, (2008) A role for brain stress systems in addiction. Neuron 59: 11-34. (Pubitemid 351905857)
32. Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, O'Dell LE, Parsons LH, Sanna PP, (2004) Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27: 739-749. (Pubitemid 38199606)
33. Koob GF, Bloom FE, (1982) Behavioral effects of neuropeptides: endorphins and vasopressin. Annu Rev Physiol 44: 571-582. (Pubitemid 12039553)
34. Koob GF, Le Moal M, (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278: 52-58. (Pubitemid 27446270)
35. Kreek MJ, Koob GF, (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51: 23-47. (Pubitemid 28353754)
36. Lack AK, Floyd DW, McCool BA, (2005) Chronic ethanol ingestion modulates proanxiety factors expressed in rat central amygdala. Alcohol 36: 83-90. (Pubitemid 43034630)
37. Le Moal M, Dantzer R, Mormede P, Baduel A, Lebrun C, Ettenberg A, van der Kooy D, Wenger J, Deyo S, Koob GF, (1984) Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesis. Psychoneuroendocrinology 9: 319-341. (Pubitemid 15181537)
38. Le AD, Kalant H, Khanna JM, (1982) Interaction between des-glycinamide9-[Arg8]vasopressin and serotonin on ethanol tolerance. Eur J Pharmacol 80: 337-345. (Pubitemid 12032164)
39. Lolait SJ, Stewart LQ, Jessop DS, Young WS, 3rd, O'Carroll AM, (2007) The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology 148: 849-856. (Pubitemid 46150781)
40. Neumann ID, Wigger A, Torner L, Holsboer F, Landgraf R, (2000) Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo- pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus. J Neuroendocrinol 12: 235-243. (Pubitemid 30156515)
41. O'Dell LE, Roberts AJ, Smith RT, Koob GF, (2004) Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol Clin Exp Res 28: 1676-1682. (Pubitemid 39551828)
42. Pittman QJ, Rogers J, Bloom FE, (1982) Arginine vasopressin deficient Brattleboro rats fail to develop tolerance to the hypothermic effects of ethanol. Regulatory Peptides 4: 33-41.
43. Rabadan-Diehl C, Martinez A, Volpi S, Subburaju S, Aguilera G, (2007) Inhibition of vasopressin V1b receptor translation by upstream open reading frames in the 5â-untranslated region. J Neuroendocrinol 19: 309-319. (Pubitemid 46372133)
44. Richardson HN, Zhao Y, Fekete EM, Funk CK, Wirsching P, Janda KD, Zorrilla EP, Koob GF, (2008) MPZP: a novel small molecule corticotropin- releasing factor type 1 receptor (CRF1) antagonist. Pharmacol Biochem Behav 88: 497-510. (Pubitemid 350266794)
45. Roberts AJ, Heyser CJ, Cole M, Griffin P, Koob GF, (2000) Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22: 581-594. (Pubitemid 30219402)
46. Salome N, Stemmelin J, Cohen C, Griebel G, (2006) Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats. Psychopharmacology 187: 237-244. (Pubitemid 44015618)
47. Samson HH, (1986) Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. Alcohol Clin Exp Res 10: 436-442. (Pubitemid 16034366)
48. Sanna PP, Simpson C, Lutjens R, Koob G, (2002) ERK regulation in chronic ethanol exposure and withdrawal. Brain Res 948: 186-191. (Pubitemid 35283780)
49. Schonberger M, Leggett C, Kim SW, Hooker JM, (2010) Synthesis of [11C]SSR149415 and preliminary imaging studies using positron emission tomography. Bioorg Med Chem Lett 20: 3103-3106.
50. Schulteis G, Markou A, Cole M, Koob GF, (1995) Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci U S A 92: 5880-5884.
51. Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS, Heilig MA, (2008) Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol Psychiatry 63: 139-145. (Pubitemid 350299311)
52. Stemmelin J, Lukovic L, Salome N, Griebel G, (2005) Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415. Neuropsychopharmacology 30: 35-42. (Pubitemid 40024397)
53. Substance Abuse and Mental Health Services Administration (2008) Results from the 2007 National Survey on Drug Use and Health: National Findings (Office of Applied Statistics, NSDUH Series H-34, DHHS Publication No. SMA 08-4343) Rockville, MD.
54. Surget A, Belzung C, (2008) Involvement of vasopressin in affective disorders. Eur J Pharmacol 583: 340-349.
55. Szabo G, Tabakoff B, Hoffman PL, (1988) Receptors with V1 characteristics mediate the maintenance of ethanol tolerance by vasopressin. J Pharmacol Exp Ther 247: 536-541.
56. Veinante P, Freund-Mercier MJ, (1997) Distribution of oxytocin- and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study. J Comp Neurol 383: 305-325. (Pubitemid 27280078)
57. Volpi S, Liu Y, Aguilera G, (2006) Vasopressin increases GAGA binding activity to the V1b receptor promoter through transactivation of the MAP kinase pathway. J Mol Endocrinol 36: 581-590. (Pubitemid 43904948)
58. Volpi S, Rabadan-Diehl C, Cawley N, Aguilera G, (2002) Transcriptional regulation of the pituitary vasopressin V1b receptor involves a GAGA-binding protein. J Biol Chem 277: 27829-27838. (Pubitemid 34966728)
59. Walker BM, Koob GF, (2008) Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33: 643-652.
60. Zhou Y, Leri F, Cummins E, Hoeschele M, Kreek MJ, (2008) Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin. Neuropsychopharmacology 33: 226-236. (Pubitemid 350243360)
61. Zhou Y, Proudnikov D, Vuferov V, Kreek MJ, (2010) Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases. Brain Res 1314: 235-252.
62. Zimmermann U, Spring K, Wittchen HU, Himmerich H, Landgraf R, Uhr M, Holsboer F, (2004) Arginine vasopressin and adrenocorticotropin secretion in response to psychosocial stress is attenuated by ethanol in sons of alcohol-dependent fathers. J Psychiatric Res 38: 385-393.